Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Oxy2Pro

K-Number: K222511 · 2023-11-21

Decision Date2023-11-21
Product CodeCCK
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

Oxy2Pro is the device name listed in this FDA 510(k) record. The listed applicant is Southmedic, Inc.. It received FDA 510(k) clearance on 2023-11-21 under 510(k) number K222511. The device is classified under product code CCK. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Oxy2Pro?

Oxy2Pro is a medical device that received FDA 510(k) clearance on 2023-11-21. The listed applicant is Southmedic, Inc.. The 510(k) number is K222511.

When did Oxy2Pro receive FDA 510(k) clearance?

Oxy2Pro received FDA 510(k) clearance on 2023-11-21, under 510(k) number K222511.

Who is the listed applicant for Oxy2Pro?

The FDA 510(k) record lists Southmedic, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Oxy2Pro?

The FDA product code for Oxy2Pro is CCK.

Related Devices (Code: CCK)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.